Friday 6 November 2026 Export AVTR’s income statement to Excel — free account

Avantor, Inc.

AVTR Healthcare Medical Instruments & Supplies

Avantor, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.6 billion, down 3.41% from fiscal 2024.

Revenue: +4.59%
EPS: +128.9%
Free cash flow: −9.03%
Total debt: −4.51%

Quarter to September 2026, against a year earlier

Insider buying

15.22 0.08 +0.53%

Follow AVTR

Alert me

Market cap: $10.3B
P/E: 30.3×
Fwd P/E: 34.8×
Dividend yield: —
F-score: 4/9
Altman Z: 1.55
Beneish M: −2.91
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Avantor, Inc. 10-Q filed Aug 1, 2025

Fiscal Q2 2025 · Period ended Jun 30, 2025 · Filed Aug 1, 2025 · accepted 9:00 AM ET · Document on sec.gov · Filing index

Nothing in this filing raised a red flag. The document itself is on sec.gov.

Read the filing on sec.gov